Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 16, Number 2—February 2010

Letter

Detection of Pandemic (H1N1) 2009 Virus in Patients Treated with Oseltamivir

David BoutolleauComments to Author , Nadhira Houhou, Claire Deback, Henri Agut, and Françoise Brun-Vézinet
Author affiliations: Université Pierre et Marie Curie 6, Paris, France; (D. Boutolleau, C. Deback, H. Agut); Pitié-Salpêtrière University Hospitals, Paris (D. Boutolleau, C. Deback, H. Agut); Bichat-Claude Bernard University Hospital, Paris (N. Houhou, F. Brun-Vézinet)

Main Article

Figure

Duration of pandemic (H1N1) 2009 excretion in nasal swabs from patients treated with oseltamivir. The number of days from start of oseltamivir treatment to achievement of negative results of reverse transcription–PCR (RT-PCR) is indicated for 16 patients. The 3 patients classified in the last group (>5 days) are 1 patient with a negative RT-PCR result on day 7 posttreatment and 2 patients who still had positive results on day 5 posttreatment but provided no additional sample for testing.

Figure. Duration of pandemic (H1N1) 2009 excretion in nasal swabs from patients treated with oseltamivir. The number of days from start of oseltamivir treatment to achievement of negative results of reverse transcription–PCR (RT-PCR) is indicated for 16 patients. The 3 patients classified in the last group (>5 days) are 1 patient with a negative RT-PCR result on day 7 posttreatment and 2 patients who still had positive results on day 5 posttreatment but provided no additional sample for testing.

Main Article

TOP